ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Thyroid, Pregnenolone, Progesterone, DHEA, etc
Thyroid, DHEA, Pregnenolone, Progesterone, etc
Effect of metformin on thyroid stimulating hormone and thyroid volume in patients with prediabetes
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 79377" data-attributes="member: 3"><p><strong>Is it true that Metformin has a negative effect on the thyroid?</strong></p><p><strong></strong></p><p>The study of Fournier et al. (1) a transverse observation study where data from 65626 patients who received metformin between 1988 and 2012 were collected, were divided into two cohorts of which one was composed of 5689 hypothyroids and 59937 eutroids. The aim was to see the correlation between metformin use and low TSH levels; the analysis showed that in hypothyroidism the risk of low levels of TSH increased by 55% compared with euthyroid drugs; Ok, all this can suffice to affirm a pathologic causal link between metformin and lower TSH levels? NO sure no!</p><p></p><p>In literature, the evidence on this correlation tells a somewhat different story if only to be analyzed, in Karimifar et al. (2) andomized double-blind placebo controlled (far different from observational retrospective analysis) were analyzed The effects of metformin on the thyroid for 3 months in 89 pre-diabetic subjects divided into two groups, in which the values &#8203;&#8203;of TSH were measured, but also the glandular volume (in addition to the anthropometric measurements). The metformin group protocol included a scaling dose of 500mg to 1500mg based on subjective tolerance but no less than 500mg. The results of the study were that metformin did not significantly affect TSH alteration, But dividing the group into two subgroups based on baseline TSH values &#8203;&#8203;(ie 0.3-2.5 &#956;U / ml and 2.6-5.5 &#956;U / ml) it was seen that a significant reduction in TSH occurred in the group showing higher basal values ; No significant difference between the first and the subsequent on the average nodular volume in both groups, but isolating the solid nodules was seen to have decreased their volume in the metformin group. As for insulin resistance, it obviously showed a significant reduction in the metformin group compared to baseline values. But isolating the solid nodules was seen to have decreased their volume in the metformin group. As for insulin resistance, it obviously showed a significant reduction in the metformin group compared to baseline values. But isolating the solid nodules was seen to have decreased their volume in the metformin group. As for insulin resistance, it obviously showed a significant reduction in the metformin group compared to baseline values.</p><p></p><p>Now the causal correlation between metformin and low TSH levels does not seem as reliable as it may have seemed from a surface analysis.</p><p></p><p>A retrospective analysis prior to Fournier et al. Conducted by an Italian team (Cappeli et al. (3) 2012) a sample of 393 Euthyroid Diabetic subjects was divided into 3 groups, the group taking only metformin (203 subjects) showed a significant reduction in TSH only in the subgroup With baseline values &#8203;&#8203;of between 2.51 mIU / 4.5 mIU / m and not in that with &#8805; 2.5 mIU values &#8203;&#8203;/ the important thing is that fT4 levels have not changed at the end of treatment in all 3 groups .</p><p></p><p>By itself, the reduction in TSH does not mean anything but contextualization.</p><p></p><p>In a previous work by Cappell et al. (4) the metformin group formed by diabetic patients with mild hypothyroidism (mean values &#8203;&#8203;of 4.5mIU / l TSH) had reported a reduction in TSH at 2,93mIU / l after 1 year Without ever going down to levels lower than normal; Both here and in the other groups, the values &#8203;&#8203;of fT4 and other parameters were not changed as a result of TSH reduction.</p><p></p><p>In short, what we can extrapolate is that metformin has shown to reduce TSH only in hypothyroidism who showed baseline TSH values &#8203;&#8203;in the medium to high ranges and not in those in the mid-low range, furthermore the values &#8203;&#8203;of fT4 and others Thyroid parameters have not changed; No significant change occurred in euthyroid subjects.</p><p></p><p><a href="https://teamolympusblog.wordpress.com/2017/01/11/metformina-caratteristiche-e-uso-nel-body-building/" target="_blank">Source</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 79377, member: 3"] [B]Is it true that Metformin has a negative effect on the thyroid? [/B] The study of Fournier et al. (1) a transverse observation study where data from 65626 patients who received metformin between 1988 and 2012 were collected, were divided into two cohorts of which one was composed of 5689 hypothyroids and 59937 eutroids. The aim was to see the correlation between metformin use and low TSH levels; the analysis showed that in hypothyroidism the risk of low levels of TSH increased by 55% compared with euthyroid drugs; Ok, all this can suffice to affirm a pathologic causal link between metformin and lower TSH levels? NO sure no! In literature, the evidence on this correlation tells a somewhat different story if only to be analyzed, in Karimifar et al. (2) andomized double-blind placebo controlled (far different from observational retrospective analysis) were analyzed The effects of metformin on the thyroid for 3 months in 89 pre-diabetic subjects divided into two groups, in which the values ​​of TSH were measured, but also the glandular volume (in addition to the anthropometric measurements). The metformin group protocol included a scaling dose of 500mg to 1500mg based on subjective tolerance but no less than 500mg. The results of the study were that metformin did not significantly affect TSH alteration, But dividing the group into two subgroups based on baseline TSH values ​​(ie 0.3-2.5 μU / ml and 2.6-5.5 μU / ml) it was seen that a significant reduction in TSH occurred in the group showing higher basal values ; No significant difference between the first and the subsequent on the average nodular volume in both groups, but isolating the solid nodules was seen to have decreased their volume in the metformin group. As for insulin resistance, it obviously showed a significant reduction in the metformin group compared to baseline values. But isolating the solid nodules was seen to have decreased their volume in the metformin group. As for insulin resistance, it obviously showed a significant reduction in the metformin group compared to baseline values. But isolating the solid nodules was seen to have decreased their volume in the metformin group. As for insulin resistance, it obviously showed a significant reduction in the metformin group compared to baseline values. Now the causal correlation between metformin and low TSH levels does not seem as reliable as it may have seemed from a surface analysis. A retrospective analysis prior to Fournier et al. Conducted by an Italian team (Cappeli et al. (3) 2012) a sample of 393 Euthyroid Diabetic subjects was divided into 3 groups, the group taking only metformin (203 subjects) showed a significant reduction in TSH only in the subgroup With baseline values ​​of between 2.51 mIU / 4.5 mIU / m and not in that with ≥ 2.5 mIU values ​​/ the important thing is that fT4 levels have not changed at the end of treatment in all 3 groups . By itself, the reduction in TSH does not mean anything but contextualization. In a previous work by Cappell et al. (4) the metformin group formed by diabetic patients with mild hypothyroidism (mean values ​​of 4.5mIU / l TSH) had reported a reduction in TSH at 2,93mIU / l after 1 year Without ever going down to levels lower than normal; Both here and in the other groups, the values ​​of fT4 and other parameters were not changed as a result of TSH reduction. In short, what we can extrapolate is that metformin has shown to reduce TSH only in hypothyroidism who showed baseline TSH values ​​in the medium to high ranges and not in those in the mid-low range, furthermore the values ​​of fT4 and others Thyroid parameters have not changed; No significant change occurred in euthyroid subjects. [URL="https://teamolympusblog.wordpress.com/2017/01/11/metformina-caratteristiche-e-uso-nel-body-building/"]Source[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Thyroid, Pregnenolone, Progesterone, DHEA, etc
Thyroid, DHEA, Pregnenolone, Progesterone, etc
Effect of metformin on thyroid stimulating hormone and thyroid volume in patients with prediabetes
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top